Background We previously investigated the association between 5 “first-generation”
measures of epigenetic aging and cancer risk in the Melbourne Collaborative Cohort Study …

The association between aging and cancer is complex. Recent studies have developed
measures of biological aging based on DNA methylation and called them “age …

Cancer is well established as an age‐associated disease, and there is substantial overlap in
the molecular, cellular and physiological changes observed with both ageing and the …

Cancer is largely an aging disease. Accelerated biological aging may be the strongest
predictor of cancer and other chronic disease risks. In the absence of reliable and …

Background Previous studies have shown that three DNA methylation (DNAm) based
algorithms of aging, DNAm PhenoAge acceleration (AgeAccelPheno), DNAm GrimAge …

Lung cancer is considered an age-associated disease, whose progression is in part due to
accumulation of genomic instability as well as age-related decline in system integrity and …

Measures of biological age based on blood DNA methylation, referred to as age
acceleration (AA), have been developed. We examined whether AA was associated with …

Background Previous studies have developed models predicting methylation age from DNA
methylation in blood and other tissues (epigenetic clock) and suggested the difference …

Background Chronological age is a prominent risk factor for many types of cancers including
colorectal cancer (CRC). Yet, the risk of CRC varies substantially between individuals, even …

Abstract Changes in blood epigenetic age have been associated with several pathological
conditions and have recently been described to anticipate cancer development. In this work …